Published financial brief
3274B
APRIA HEALTHCARE GROUP INC
- As of
- 2012-12-31
- Source
- Supabase fundamentals
- Calculator
- financial-roic-1.0.0
- Published
- 7/26/2026
3 data notes
- Only 3 of 5 periods.
- Input provenance requires review.
- One or more values are unavailable.
Exact-period record
Fundamentals
3 reported periods
| Metric | FY 20102010-12-31 | FY 20112011-12-31 | FY 20122012-12-31 |
|---|---|---|---|
| Financial statements | |||
| RevenueUSD millions | 2,080.7 | 2,301.4 | 2,436.2 |
| Cost of goods soldUSD millions | 709.7 | 805.7 | 919.9 |
| Selling, general and administrative expenseUSD millions | 1,137.8 | 1,295 | 1,310.2 |
| Depreciation and amortizationUSD millions | 128.7 | 133.6 | 114 |
| Net incomeUSD millions | -17.4 | -747.3 | -260.4 |
| Operating profit (EBIT)USD millions | 104.6 | 67.1 | 92.2 |
| Income taxesUSD millions | -7.9 | 24.7 | -130.9 |
| Short-term debtUSD millions | 1.3 | 10.3 | 25.2 |
| Long-term debtUSD millions | 1,018.1 | 1,017.8 | 1,017.5 |
| Cash and equivalentsUSD millions | 109.1 | 29.1 | 27.1 |
| ReceivablesUSD millions | 282.8 | 337.2 | 344.4 |
| InventoryUSD millions | 73.9 | 57.7 | 68.1 |
| PayablesUSD millions | 86.6 | 135.6 | 157.5 |
| Net property, plant and equipmentUSD millions | 253.8 | 250.5 | 263.3 |
| Capital expenditureUSD millions | 117 | 163.1 | 149.7 |
| Operating cash flowUSD millions | 84.6 | 101.8 | 85.6 |
| Prepaid expensesUSD millions | —missing | —missing | —missing |
| AccrualsUSD millions | 149.5 | 136.3 | 145 |
| EBITDAUSD millions | 233.3 | 200.7 | 206.2 |
| Working capitalUSD millions | 283.2 | 140.9 | 103.8 |
| Working capital requirementUSD millions | 270.1 | 259.3 | 255 |
| Total debtUSD millions | 1,019.4 | 1,028.1 | 1,042.7 |
| Free cash flowUSD millions | -32.5 | -61.3 | -64 |
| Unlevered free cash flowUSD millions | 83.6 | 48.4 | 30 |
| Returns and ratios | |||
| ROICratio | 2.7% | 4.4% | 5.2% |
| Pre-tax ROICratio | 4% | 4.4% | 7.9% |
| Effective tax rateratio | 31.2% | 0% | 33.5% |
| Revenue growthratio | —missing | 10.6% | 5.9% |
| EBIT / Revenueratio | 5% | 2.9% | 3.8% |
| Revenue / Invested capitalmultiple | 0.79× | 1.52× | 2.08× |
| Cogs Over Revenuesratio | 34.1% | 35% | 37.8% |
| Sga Over Revenuesratio | 54.7% | 56.3% | 53.8% |
| Da Over Revenuesratio | 6.2% | 5.8% | 4.7% |
| Nfa Over Revenuesratio | 12.2% | 10.9% | 10.8% |
| Wcr Over Revenuesratio | 13% | 11.3% | 10.5% |
| Debt Over Ebitdamultiple | 4.37× | 5.12× | 5.06× |
| St Debt Over Cashmultiple | 0.01× | 0.35× | 0.93× |
| Interest Over Ebitdamultiple | 0.56× | 0.66× | 0.65× |
| Interest Over Nocf Nicfmultiple | -4.03× | -2.16× | -2.11× |
| Nsf Over Wcrmultiple | -0.4× | -0.07× | -0.01× |
Ask this snapshot
Research assistant
3274B · annualSnapshot fe774fff
Answers use only this published snapshot. The assistant will say when the data is insufficient and does not create forecasts, scenarios, or investment advice.
0 / 2,000